天然物中のフェノール酸の配列ベースプロファイリングのために配位子疎水性を変調することによるCu-MOFナノ酵素の微小環境の工学
Kaiqiang Yang1, Junlei Liu1, Yiming Yang1
1School of Materials Science and Chemical Engineering, Ningbo University, Ningbo, 315211, China.
Abstract:
Natural products and their synthetic analogs have historically been fundamental to drug discovery, making their identification crucial for pharmaceutical research. This work presents a nanozyme-based sensor array for precise discrimination and quantitative determination of seven phenolic acids in plant-derived natural products. By modulating ligand hydrophobicity, we engineered three POD-mimicking Cu-MOF nanozymes (Cu-MI, Cu-EI, and Cu-PI), with their catalytic activity exhibiting increased catalytic activity proportional to the ligand alkyl chain length. Based on this, a four-channel sensor array was constructed using the distinct activities of Cu-MI and Cu-PI. In this array, the target phenolic acids selectively inhibit the nanozyme-catalyzed oxidation of 3,3',5,5'-tetramethylbenzidine (TMB), generating unique fingerprint-like responses for each analyte. The array achieved 100 % accurate classification of all seven phenolic acids using linear discriminant analysis (LDA) and hierarchical cluster analysis (HCA). Furthermore, the array allowed for the sensitive quantification of phenolic acids, offering a wide linear range (5-50 μM, R2 > 0.99) and low detection limits (0.56-4.1 μM). The practical utility was rigorously validated through interference tests and the analysis of Lonicera japonica extracts. The assay accurately identified chlorogenic acid as the predominant phenolic acid in Lonicera japonica, determined its content, and demonstrated excellent accuracy with spike recoveries of 94.5-103.2 %. This study establishes a robust and reliable strategy for the quality assessment of natural products.
さらに関連する動画
07:37Click-Chemistry Based Fluorometric Assay for Apolipoprotein N-acyltransferase from Enzyme Characterization to High-Throughput Screening
Published on: May 13, 2020
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
